High or low doses of almitrine bismesylate in ARDS patients responding to inhaled NO and receiving norepinephrine?

Roch, A; Papazian, L; Bregeon, F; Gainnier, M; Michelet, P; Thirion, X; Saux, P; Thomas, P; Jammes, Y; Auffray, J P

Roch, A; Papazian, L; Bregeon, F; Gainnier, M; Michelet, P; Thirion, X; Saux, P; Thomas, P; Jammes, Y; Auffray, J P.

Affiliation

Roch A; Service de Réanimation Polyvalente, Hôpitaux Sud, Marseille, France.

Intensive Care Med ; 27(11): 1737-43, 2001 Nov.

Article in En | MEDLINE | ID: mdl-11810116

Subject(s)

Almitrine/administration & dosage; Pulmonary Gas Exchange/drug effects; Respiratory Distress Syndrome/drug therapy; Respiratory System Agents/administration & dosage; Administration, Inhalation; Adrenergic alpha-Agonists/administration & dosage; Analysis of Variance; Bronchodilator Agents/administration & dosage; Female; Hemodynamics/drug effects; Humans; Infusions, Intravenous; Male; Middle Aged; Nitric Oxide/administration & dosage; Norepinephrine/administration & dosage; Oxygen/metabolism; Prospective Studies; Respiratory Distress Syndrome/complications; Shock, Septic/complications; Shock, Septic/drug therapy; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Distress Syndrome / Almitrine / Pulmonary Gas Exchange / Respiratory System Agents Type of study: Observational_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Intensive Care Med Year: 2001 Document type: Article

Search on Google

XML

PubMed Links